Screener
Allocation of facilities and IT expenses
Veracyte·Products & Services·3 segments
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Testing revenue | $3.37M | $3.41M | $3.2M | $3.59M | $2.96M |
| Product revenue | $197K | $222K | $36K | $12K | $3K |
| Biopharmaceutical and other revenue | $414K | $458K | $53K | $0 | $0 |
| Total | $3.37M | $3.41M | $3.2M | $3.59M | $2.96M |